Table 1.
Baseline characteristics.
| Variable | Overall (N=1606) |
|
|---|---|---|
| Follow-up (years), mean ±SD | 5.5 | ±3.4 |
| Age (years), mean ± SD | 69.8 | ± 12.6 |
| Women | 872 | (54%) |
| White | 1526 | (95%) |
| Black | 18 | (1%) |
| Congestive Fleart Failure | 397 | (25%) |
| Flypertension | 1201 | (75%) |
| Diabetes Mellitus | 682 | (42%) |
| Stroke/TIA/Embolism | 464 | (29%) |
| Vascular Disease | 984 | (61%) |
| Chronic Kidney Disease Stage* (mL/min) | ||
| 1 (90+) | 99 | (6%) |
| 2 (60 to 89) | 589 | (37%) |
| 3 (30 to 59) | 389 | (24%) |
| 4 (15 to 29) | 37 | (2%) |
| 5 (< 15 or Hemodialysis) | 13 | (1%) |
| Renal Impairment† | 207 | (13%) |
| CHA2DS2-VASc Score at Baseline | ||
| 0 | 52 | (3%) |
| 1 | 146 | (9%) |
| 2 | 201 | (13%) |
| 3 | 238 | (15%) |
| 4 | 280 | (17%) |
| 5 | 238 | (15%) |
| 6 | 194 | (12%) |
| 7 | 145 | (9%) |
| 8 | 85 | (5%) |
| 9 | 27 | (2%) |
| Oral Anticoagulation | 136 | (8%) |
SD = standard deviation
*
Defined by GFR data. The total number of patients with GFR data available was 1127 (70%)
†
CKD stage 3 or greater defined by ICD-9 codes for the total population (n=l,606).